新型真菌（单端孢霉）播散性感染的小鼠模型及泊沙康唑的成功治疗。
Murine model of a disseminated infection by the novel fungus Fonsecaea monophora and successful treatment with posaconazole.
机构信息
Unitat de Microbiologia, Facultat de Medicina i Ciències de la Salut, IISPV, Universitat Rovira i Virgili, Carrer Sant Llorenç, 21.43201 Reus, Spain.
出版信息
Antimicrob Agents Chemother. 2010 Feb;54(2):919-23. doi: 10.1128/AAC.01284-09. Epub 2009 Dec 14.
Abstract
We have evaluated the efficacy of posaconazole, amphotericin B, and itraconazole in a murine model of disseminated infection by Fonsecaea monophora. Of these three antifungal drugs tested, posaconazole prolonged survival significantly and reduced the fungal load in most of the organs tested. Bioassay studies demonstrated the relationship between posaconazole levels and dose escalation in serum and brain tissue. Posaconazole may have a clinical role in the treatment of disseminated infections by F. monophora.
摘要
我们评估了泊沙康唑、两性霉素 B 和伊曲康唑在毛孢子菌属（Fonsecaea monophora）播散性感染的小鼠模型中的疗效。在这三种测试的抗真菌药物中，泊沙康唑显著延长了生存时间，降低了大多数测试器官中的真菌负荷。生物测定研究表明了泊沙康唑水平与血清和脑组织中剂量递增之间的关系。泊沙康唑在治疗毛孢子菌属（Fonsecaea monophora）播散性感染方面可能具有临床作用。
相似文献
1
Murine model of a disseminated infection by the novel fungus Fonsecaea monophora and successful treatment with posaconazole.
Antimicrob Agents Chemother. 2010 Feb;54(2):919-23. doi: 10.1128/AAC.01284-09. Epub 2009 Dec 14.
2
Efficacy of Posaconazole in a Murine Model of Systemic Infection by Saprochaete capitata.
Antimicrob Agents Chemother. 2015 Dec;59(12):7477-82. doi: 10.1128/AAC.01140-15. Epub 2015 Sep 21.
3
Correlation of in vitro activity, serum levels, and in vivo efficacy of posaconazole against Rhizopus microsporus in a murine disseminated infection.
Antimicrob Agents Chemother. 2009 Dec;53(12):5022-5. doi: 10.1128/AAC.01026-09. Epub 2009 Sep 28.
4
Posaconazole efficacy in a murine disseminated infection caused by Paecilomyces lilacinus.
J Antimicrob Chemother. 2009 Feb;63(2):361-4. doi: 10.1093/jac/dkn497. Epub 2008 Dec 2.
5
Efficacy of caspofungin and posaconazole in a murine model of disseminated Exophiala infection.
Med Mycol. 2007 Dec;45(8):685-9. doi: 10.1080/13693780701390157.
6
Evaluation of antifungal therapy in a neutropenic murine model of Neoscytalidium dimidiatum infection.
Int J Antimicrob Agents. 2010 Feb;35(2):152-5. doi: 10.1016/j.ijantimicag.2009.09.028. Epub 2009 Dec 14.
7
Evaluation of the efficacies of Amphotericin B, Posaconazole, Voriconazole, and Anidulafungin in a murine disseminated infection by the emerging opportunistic Fungus Sarocladium (Acremonium) kiliense.
Antimicrob Agents Chemother. 2013 Dec;57(12):6265-9. doi: 10.1128/AAC.01484-13. Epub 2013 Oct 7.
8
Efficacy of posaconazole as treatment and prophylaxis against Fusarium solani.
Antimicrob Agents Chemother. 2010 Mar;54(3):1055-9. doi: 10.1128/AAC.01445-09. Epub 2010 Jan 11.
9
Antifungal efficacy and pharmacodynamics of posaconazole in experimental models of invasive fungal infections.
Mycoses. 2006;49 Suppl 1:7-16. doi: 10.1111/j.1439-0507.2006.01296.x.
10
Experimental treatment of Curvularia infection.
Diagn Microbiol Infect Dis. 2014 Aug;79(4):428-31. doi: 10.1016/j.diagmicrobio.2014.05.004. Epub 2014 May 17.
引用本文的文献
1
Pharmacokinetics and Pharmacodynamics of Posaconazole.
Drugs. 2020 May;80(7):671-695. doi: 10.1007/s40265-020-01306-y.
2
Antifungal Drugs: Special Problems Treating Central Nervous System Infections.
J Fungi (Basel). 2019 Oct 11;5(4):97. doi: 10.3390/jof5040097.
3
Therapeutic Challenges of Non- Invasive Mold Infections in Immunosuppressed Patients.
Antimicrob Agents Chemother. 2019 Oct 22;63(11). doi: 10.1128/AAC.01244-19. Print 2019 Nov.
4
Low Central Nervous System Posaconazole Concentrations during Cerebral Phaeohyphomycosis.
Antimicrob Agents Chemother. 2019 Oct 22;63(11). doi: 10.1128/AAC.01184-19. Print 2019 Nov.
5
CYP51 as drug targets for fungi and protozoan parasites: past, present and future.
Parasitology. 2018 Dec;145(14):1820-1836. doi: 10.1017/S0031182018000562. Epub 2018 Apr 12.
6
Cladophialophora bantiana osteomyelitis in a renal transplant patient.
Med Mycol Case Rep. 2016 Jul 9;12:17-20. doi: 10.1016/j.mmcr.2016.07.002. eCollection 2016 Jun.
7
Cerebral phaeohyphomycosis by Fonsecaea monophora: Report in a patient with AIDS and a ring enhancing lesion.
Med Mycol Case Rep. 2016 Jun 20;12:4-7. doi: 10.1016/j.mmcr.2016.06.002. eCollection 2016 Jun.
8
Black yeasts and their filamentous relatives: principles of pathogenesis and host defense.
Clin Microbiol Rev. 2014 Jul;27(3):527-42. doi: 10.1128/CMR.00093-13.
9
Antifungal susceptibility patterns of opportunistic fungi in the genera Verruconis and Ochroconis.
Antimicrob Agents Chemother. 2014 Jun;58(6):3285-92. doi: 10.1128/AAC.00002-14. Epub 2014 Mar 31.
10
Tissue penetration of antifungal agents.
Clin Microbiol Rev. 2014 Jan;27(1):68-88. doi: 10.1128/CMR.00046-13.
本文引用的文献
1
Optimization of bioassay method for the quantitative microbiological determination of amphotericin B.
Mycoses. 2010 Jan;53(1):57-61. doi: 10.1111/j.1439-0507.2008.01660.x. Epub 2009 Jan 14.
2
Genetic diversity and species delimitation in the opportunistic genus Fonsecaea.
Med Mycol. 2009 Feb;47(1):17-25. doi: 10.1080/13693780802527178. Epub 2008 Dec 19.
3
Combined antifungal therapy in a murine model of disseminated infection by Cladophialophora bantiana.
Med Mycol. 2009 Feb;47(1):45-9. doi: 10.1080/13693780802526840. Epub 2008 Dec 12.
4
Molecular diversity of Fonsecaea (Chaetothyriales) causing chromoblastomycosis in southern China.
Med Mycol. 2009 Feb;47(1):27-33. doi: 10.1080/13693780802468209. Epub 2008 Oct 25.
5
Chromoblastomycosis caused by a meristematic mutant of Fonsecaea monophora.
Med Mycol. 2009 Feb;47(1):77-80. doi: 10.1080/13693780802322588. Epub 2008 Sep 15.
6
Successful treatment for chromoblastomycosis caused by Fonsecaea monophora: a report of three cases in Guangdong, China.
Mycoses. 2009 Mar;52(2):176-81. doi: 10.1111/j.1439-0507.2008.01547.x. Epub 2008 Jun 21.
7
Cerebral phaeohyphomycosis caused by Fonsecaea monophora.
Med Mycol. 2005 Aug;43(5):465-72. doi: 10.1080/13693780500220373.
8
Molecular ecology and pathogenic potential of Fonsecaea species.
Med Mycol. 2004 Oct;42(5):405-16. doi: 10.1080/13693780410001661464.
9
Posaconazole therapy of disseminated phaeohyphomycosis in a murine model.
Antimicrob Agents Chemother. 2004 Jun;48(6):2288-91. doi: 10.1128/AAC.48.6.2288-2291.2004.
10
Case study: posaconazole treatment of disseminated phaeohyphomycosis due to Exophiala spinifera.
Clin Infect Dis. 2004 Feb 1;38(3):e15-20. doi: 10.1086/380840. Epub 2004 Jan 13.
Zotero 插件